LCTX

LINEAGE CELL THERAPEUTICS IN

LCTX·53566P109·US·Common Stock·Healthcare - Biotechnology-Activist

LCTX (LINEAGE CELL THERAPEUTICS IN) is held by 71 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($13.1M), MILLENNIUM MANAGEMENT LLC ($8.8M), FIFTH THIRD BANCORP ($7.3M). Net institutional sentiment: Mixed.

71
Holders
(7 Elite)
$69.4M
Total Value
65% (65)
Consensus
42 buying - 23 selling
13F: Insider & Congress:
LCTX

Smart Money Verdict

View all
Held by 71 funds
7 elite

Who's Trading

InsiderCMCulley Brian MBuy $24KMar 12, 2026
ActivistBRBROADWOOD PARTNERS, L.P.23.0%Nov 14, 2025
ActivistCJChernett Jorey5.0%Sep 26, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
8.3M$13.1M0.0%-32.28%
39
Increased
5.6M(+163.5%)$8.8M0.0%-16.83%
44
New
4.6M$7.3M0.0%-32.28%
38
Increased
3.9M(+0.8%)$6.1M0.0%+32.41%
27
Increased
3.1M(+125.0%)$4.8M0.0%-27.32%
43
Increased
2.5M(+2.5%)$4M0.0%-5.49%
27
Decreased
2.1M(-11.6%)$3.4M0.0%+62.56%
0
Decreased
1.9M(-6.5%)$3M0.0%-0.61%
0
Increased
1.4M(+648.4%)$2.2M0.0%-26.92%
42
New
1.3M$2.1M0.0%-32.28%
36
Increased
1.3M(+84.7%)$2.1M0.0%-20.67%
40
Decreased
1.2M(-18.7%)$1.8M0.0%-14.06%
0
Increased
1.1M(+7.3%)$1.7M0.0%+4.40%
28
Decreased
993,208(-1.1%)$1.6M0.0%-14.88%
0
Increased
499,127(+4.1%)$788,6210.0%-8.04%
26
Increased
422,274(+56.8%)$667,1950.0%-24.93%
35
Increased
419,355(+112.0%)$662,5800.0%-18.57%
27
Increased
393,309(+12.8%)$621,4290.0%-21.62%
28
Increased
304,363(+90.9%)$480,8940.0%-26.36%
38
Increased
259,561(+22.8%)$410,1060.0%-22.61%
29

Showing 1-20 of 74

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used